Skip to main content
Top
Published in: BMC Cancer 1/2007

Open Access 01-12-2007 | Research article

Ductal carcinoma in situ of the breast (DCIS) with heterogeneity of nuclear grade: prognostic effects of quantitative nuclear assessment

Authors: Judith-Anne W Chapman, Naomi A Miller, H Lavina A Lickley, Jin Qian, William A Christens-Barry, Yuejiao Fu, Yan Yuan, David E Axelrod

Published in: BMC Cancer | Issue 1/2007

Login to get access

Abstract

Background

Previously, 50% of patients with breast ductal carcinoma in situ (DCIS) had more than one nuclear grade, and neither worst nor predominant nuclear grade was significantly associated with development of invasive carcinoma. Here, we used image analysis in addition to histologic evaluation to determine if quantification of nuclear features could provide additional prognostic information and hence impact prognostic assessments.

Methods

Nuclear image features were extracted from about 200 nuclei of each of 80 patients with DCIS who underwent lumpectomy alone, and received no adjuvant systemic therapy. Nuclear images were obtained from 20 representative nuclei per duct, from each of a group of 5 ducts, in two separate fields, for 10 ducts. Reproducibility of image analysis features was determined, as was the ability of features to discriminate between nuclear grades. Patient information was available about clinical factors (age and method of DCIS detection), pathologic factors (DCIS size, nuclear grade, margin size, and amount of parenchymal involvement), and 39 image features (morphology, densitometry, and texture). The prognostic effects of these factors and features on the development of invasive breast cancer were examined with Cox step-wise multivariate regression.

Results

Duplicate measurements were similar for 89.7% to 97.4% of assessed image features. For the pooled assessment with ~200 nuclei per patient, a discriminant function with one densitometric and two texture features was significantly (p < 0.001) associated with nuclear grading, and provided 78.8% correct jackknifed classification of a patient's nuclear grade. In multivariate assessments, image analysis nuclear features had significant prognostic associations (p ≤ 0.05) with the development of invasive breast cancer. Texture (difference entropy, p < 0.001; contrast, p < 0.001; peak transition probability, p = 0.01), densitometry (range density, p = 0.004), and measured margin (p = 0.05) were associated with development of invasive disease for the pooled data across all ducts.

Conclusion

Image analysis provided reproducible assessments of nuclear features which quantitated differences in nuclear grading for patients. Quantitative nuclear image features indicated prognostically significant differences in DCIS, and may contribute additional information to prognostic assessments of which patients are likely to develop invasive disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lagios MD, Margolin FR, Westdahl PR, Rose MR: Mammographically detected duct carcinoma in situ, Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer. 1989, 63: 618-624. 10.1002/1097-0142(19890215)63:4<618::AID-CNCR2820630403>3.0.CO;2-J.CrossRefPubMed Lagios MD, Margolin FR, Westdahl PR, Rose MR: Mammographically detected duct carcinoma in situ, Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer. 1989, 63: 618-624. 10.1002/1097-0142(19890215)63:4<618::AID-CNCR2820630403>3.0.CO;2-J.CrossRefPubMed
2.
go back to reference Lagios MD: Duct carcinoma in situ. Surgical Clinics of North America. 1990, 70: 853-871.PubMed Lagios MD: Duct carcinoma in situ. Surgical Clinics of North America. 1990, 70: 853-871.PubMed
3.
go back to reference van Dongen JA, Holland R, Peterse JL, Fentiman IS, Lagios MD, Millis RR, Recht A: Ductal carcinoma in-situ of the breast; Second EORTC consensus meeting. Eur J Cancer. 1992, 28: 626-629. 10.1016/S0959-8049(05)80113-3.CrossRefPubMed van Dongen JA, Holland R, Peterse JL, Fentiman IS, Lagios MD, Millis RR, Recht A: Ductal carcinoma in-situ of the breast; Second EORTC consensus meeting. Eur J Cancer. 1992, 28: 626-629. 10.1016/S0959-8049(05)80113-3.CrossRefPubMed
4.
go back to reference Silverstein MJ: Ductal carcinoma in situ of the breast: Controversial issues. The Oncologist. 1998, 3: 94-103.PubMed Silverstein MJ: Ductal carcinoma in situ of the breast: Controversial issues. The Oncologist. 1998, 3: 94-103.PubMed
5.
go back to reference Badve S, A'Hern RP, Ward AM, Millis RR, Pinder SE, Ellis IO, Gusterson BA, Sloane JP: Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: A comparative study with long follow-up. Hum Pathol. 1998, 29: 915-923. 10.1016/S0046-8177(98)90196-4.CrossRefPubMed Badve S, A'Hern RP, Ward AM, Millis RR, Pinder SE, Ellis IO, Gusterson BA, Sloane JP: Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: A comparative study with long follow-up. Hum Pathol. 1998, 29: 915-923. 10.1016/S0046-8177(98)90196-4.CrossRefPubMed
6.
go back to reference Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, Wolmark N: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of protocol B-17. Cancer. 1999, 86: 429-438. 10.1002/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO;2-Y.CrossRefPubMed Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, Wolmark N: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of protocol B-17. Cancer. 1999, 86: 429-438. 10.1002/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO;2-Y.CrossRefPubMed
7.
go back to reference Lagios MD, Silverstein MJ: Outcomes and factors impacting local recurrence of ductal carcinoma in situ. Cancer. 2000, 89: 2323-2325. 10.1002/1097-0142(20001201)89:11<2323::AID-CNCR24>3.0.CO;2-C.CrossRefPubMed Lagios MD, Silverstein MJ: Outcomes and factors impacting local recurrence of ductal carcinoma in situ. Cancer. 2000, 89: 2323-2325. 10.1002/1097-0142(20001201)89:11<2323::AID-CNCR24>3.0.CO;2-C.CrossRefPubMed
8.
go back to reference Leong AS-Y, Sormunen RT, Vinyuvat S, Hamdani RW, Suthipintawong C: Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma. A comparison of eight contemporary grading systems. Am J Clin Pathol. 2001, 115: 709-718. 10.1309/WBU9-22QN-C3NA-2Q12.CrossRefPubMed Leong AS-Y, Sormunen RT, Vinyuvat S, Hamdani RW, Suthipintawong C: Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma. A comparison of eight contemporary grading systems. Am J Clin Pathol. 2001, 115: 709-718. 10.1309/WBU9-22QN-C3NA-2Q12.CrossRefPubMed
9.
go back to reference Wärnberg F, Casalini P, Nordgren H, Bergkvist L, Holmberg L, Ménard S: Ductal carcinoma in situ of the breast: A new phenotype classification and its relation to prognosis. Breast Cancer Res Treat. 2002, 73: 215-222. 10.1023/A:1015816406078.CrossRefPubMed Wärnberg F, Casalini P, Nordgren H, Bergkvist L, Holmberg L, Ménard S: Ductal carcinoma in situ of the breast: A new phenotype classification and its relation to prognosis. Breast Cancer Res Treat. 2002, 73: 215-222. 10.1023/A:1015816406078.CrossRefPubMed
10.
go back to reference Leonard GD, Swain SM: Ductal carcinoma in situ: Complexities and challenges. J Natl Cancer Inst. 2004, 96: 906-920.CrossRefPubMed Leonard GD, Swain SM: Ductal carcinoma in situ: Complexities and challenges. J Natl Cancer Inst. 2004, 96: 906-920.CrossRefPubMed
11.
go back to reference Pathology reporting of breast disease. NHSBSP Publication No. 58. 2005 Pathology reporting of breast disease. NHSBSP Publication No. 58. 2005
12.
go back to reference Miller NA, Chapman J, Fish EB, Link MA, Fishell E, Wright B, Lickley HLA, McCready DR, Hanna WM: In situ duct carcinoma of the breast: Clinical and histologic factors and association with recurrent carcinoma. The Breast Journal. 2001, 7: 292-302. 10.1046/j.1524-4741.2001.99124.x.CrossRefPubMed Miller NA, Chapman J, Fish EB, Link MA, Fishell E, Wright B, Lickley HLA, McCready DR, Hanna WM: In situ duct carcinoma of the breast: Clinical and histologic factors and association with recurrent carcinoma. The Breast Journal. 2001, 7: 292-302. 10.1046/j.1524-4741.2001.99124.x.CrossRefPubMed
13.
go back to reference Chapman JW, Miller NA, Lickley HLA, Hanna WM, McCready DR, Link MA, Fishell E, Wright B, Hiraki GY, Ross TM, Fish EB: Assessment of treatment for patients with primary ductal carcinoma in situ in the breast. Ann Surg Oncol. 1999, 6: 510-511. 10.1007/s10434-999-0510-9.CrossRef Chapman JW, Miller NA, Lickley HLA, Hanna WM, McCready DR, Link MA, Fishell E, Wright B, Hiraki GY, Ross TM, Fish EB: Assessment of treatment for patients with primary ductal carcinoma in situ in the breast. Ann Surg Oncol. 1999, 6: 510-511. 10.1007/s10434-999-0510-9.CrossRef
14.
go back to reference Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ER: Prognostic classification of breast ductal carcinoma in situ. Lancet. 1995, 345: 1154-1157. 10.1016/S0140-6736(95)90982-6.CrossRefPubMed Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ER: Prognostic classification of breast ductal carcinoma in situ. Lancet. 1995, 345: 1154-1157. 10.1016/S0140-6736(95)90982-6.CrossRefPubMed
16.
go back to reference Russ JC: Computer-assisted Microscopy: The Measurement and Analysis of Images. 1990, New York: Plenum PressCrossRef Russ JC: Computer-assisted Microscopy: The Measurement and Analysis of Images. 1990, New York: Plenum PressCrossRef
17.
go back to reference Haralick RM, Shanmugam K, Dinstein I: Texture features for image classification. IEEE Trans Systems Man and Cybernetics. 1973, SMC-3: 610-621.CrossRef Haralick RM, Shanmugam K, Dinstein I: Texture features for image classification. IEEE Trans Systems Man and Cybernetics. 1973, SMC-3: 610-621.CrossRef
18.
19.
go back to reference Habel LA, Moe RE, Daling JR, Holte S, Rossing MA, Weiss NS: Risk of contralateral breast cancer among women with carcinoma in situ of the breast. Ann Surgery. 1997, 225: 669-675.CrossRef Habel LA, Moe RE, Daling JR, Holte S, Rossing MA, Weiss NS: Risk of contralateral breast cancer among women with carcinoma in situ of the breast. Ann Surgery. 1997, 225: 669-675.CrossRef
20.
go back to reference Wärnberg F, Bergh J, Zack M, Holmberg L: Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: A population-based case-control study in Sweden. Cancer Epidemiol Biomark Prev. 2001, 10: 495-499. Wärnberg F, Bergh J, Zack M, Holmberg L: Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: A population-based case-control study in Sweden. Cancer Epidemiol Biomark Prev. 2001, 10: 495-499.
21.
go back to reference Wong JS, Kaelin CM, Troyan SL, Gadd MA, Gelman R, Lester SC, Schnitt SJ, Sgroi DC, Silver BJ, Harris JR, Smith BL: Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 2006, 24: 1031-1036. 10.1200/JCO.2005.02.9975.CrossRefPubMed Wong JS, Kaelin CM, Troyan SL, Gadd MA, Gelman R, Lester SC, Schnitt SJ, Sgroi DC, Silver BJ, Harris JR, Smith BL: Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 2006, 24: 1031-1036. 10.1200/JCO.2005.02.9975.CrossRefPubMed
22.
go back to reference Tan PH, Goh BB, Ching G, Bay BH: Correlation of nuclear morphometry with pathologic parameters in ductal carcinoma in situ of the breast. Mod Pathol. 2001, 14: 937-941. 10.1038/modpathol.3880415.CrossRefPubMed Tan PH, Goh BB, Ching G, Bay BH: Correlation of nuclear morphometry with pathologic parameters in ductal carcinoma in situ of the breast. Mod Pathol. 2001, 14: 937-941. 10.1038/modpathol.3880415.CrossRefPubMed
23.
go back to reference Sneige N, Lagios MD, Schwarting R, Colburn W, Atkinson E, Weber D, Sahin A, Kemp B, Hoque A, Risin S, Sabichi A, Boone C, Dhingra K, Kelloff G, Lippman S: Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ. Hum Pathol. 1999, 30: 257-262. 10.1016/S0046-8177(99)90002-3.CrossRefPubMed Sneige N, Lagios MD, Schwarting R, Colburn W, Atkinson E, Weber D, Sahin A, Kemp B, Hoque A, Risin S, Sabichi A, Boone C, Dhingra K, Kelloff G, Lippman S: Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ. Hum Pathol. 1999, 30: 257-262. 10.1016/S0046-8177(99)90002-3.CrossRefPubMed
24.
go back to reference Rosa GJM, Steibel JP, Templeman RJ: Reassessing design and analysis of two-colour microarray experiments using mixed effects models. Comp Funct Genom. 2005, 6: 123-131. 10.1002/cfg.464.CrossRef Rosa GJM, Steibel JP, Templeman RJ: Reassessing design and analysis of two-colour microarray experiments using mixed effects models. Comp Funct Genom. 2005, 6: 123-131. 10.1002/cfg.464.CrossRef
25.
go back to reference Böcking A, Stockhausen J, Meyer-Ebrecht D: Towards a single cell cancer diagnosis: Multimodal and monocellular measurements of markers and morphology (5M). Cell Oncol. 2004, 26: 73-79.PubMedPubMedCentral Böcking A, Stockhausen J, Meyer-Ebrecht D: Towards a single cell cancer diagnosis: Multimodal and monocellular measurements of markers and morphology (5M). Cell Oncol. 2004, 26: 73-79.PubMedPubMedCentral
26.
go back to reference Lagios MD, Page DL, Silverstein MJ: Prospective study of wide excision alone for ductal carcinoma in situ of the breast. (Letter to the Editor). J Clin Oncol. 2006, 24: 3809-3811. 10.1200/JCO.2006.06.9989.CrossRefPubMed Lagios MD, Page DL, Silverstein MJ: Prospective study of wide excision alone for ductal carcinoma in situ of the breast. (Letter to the Editor). J Clin Oncol. 2006, 24: 3809-3811. 10.1200/JCO.2006.06.9989.CrossRefPubMed
27.
go back to reference Peinta KJ, Coffey DS: Correlation of nuclear morphometry with progression of breast cancer. Cancer. 1991, 68: 2012-2016. 10.1002/1097-0142(19911101)68:9<2012::AID-CNCR2820680928>3.0.CO;2-C.CrossRef Peinta KJ, Coffey DS: Correlation of nuclear morphometry with progression of breast cancer. Cancer. 1991, 68: 2012-2016. 10.1002/1097-0142(19911101)68:9<2012::AID-CNCR2820680928>3.0.CO;2-C.CrossRef
28.
go back to reference Susnik B, Worth A, Palcic B, Poulin N, LeRiche J: Differences in quantitative nuclear features between ductal carcinoma in situ (DCIS) with and without accompanying invasive carcinoma in the surrounding breast. Analyt Cell Pathol. 1995, 8: 39-52. Susnik B, Worth A, Palcic B, Poulin N, LeRiche J: Differences in quantitative nuclear features between ductal carcinoma in situ (DCIS) with and without accompanying invasive carcinoma in the surrounding breast. Analyt Cell Pathol. 1995, 8: 39-52.
29.
go back to reference Wolberg WH, Street N, Heisey DM, Mangasarian OL: Computer-derived nuclear features distinguish malignant from benign breast cytology. Hum Pathol. 1995, 26: 792-796. 10.1016/0046-8177(95)90229-5.CrossRefPubMed Wolberg WH, Street N, Heisey DM, Mangasarian OL: Computer-derived nuclear features distinguish malignant from benign breast cytology. Hum Pathol. 1995, 26: 792-796. 10.1016/0046-8177(95)90229-5.CrossRefPubMed
30.
go back to reference Aubele M, Auer G, Höfler H: Analysis of DNA and morphometry in breast carcinoma. Histochem Cell Biol. 1996, 106: 241-245.CrossRefPubMed Aubele M, Auer G, Höfler H: Analysis of DNA and morphometry in breast carcinoma. Histochem Cell Biol. 1996, 106: 241-245.CrossRefPubMed
31.
go back to reference Giardina C, Renzuli G, Serio G, Caniglia DM, Lettini T, Ferri C, D'Eredità G, Ricco R, Delfino VP: Nuclear morphometry in node-negative breast carcinoma. Analyt Quant Cytol Histol. 1996, 18: 374-382. Giardina C, Renzuli G, Serio G, Caniglia DM, Lettini T, Ferri C, D'Eredità G, Ricco R, Delfino VP: Nuclear morphometry in node-negative breast carcinoma. Analyt Quant Cytol Histol. 1996, 18: 374-382.
32.
go back to reference Kronqvist P, Kuopio T, Jalava P, Collan Y: Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer. Br J Cancer. 2002, 87: 1275-1280. 10.1038/sj.bjc.6600617.CrossRefPubMedPubMedCentral Kronqvist P, Kuopio T, Jalava P, Collan Y: Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer. Br J Cancer. 2002, 87: 1275-1280. 10.1038/sj.bjc.6600617.CrossRefPubMedPubMedCentral
33.
go back to reference Carpenter R, Gibbs N, Matthews J, Cooke T: Importance of cellular DNA content in pre-malignant breast disease and pre-invasive carcinoma of the female breast. Br J Surg. 1985, 74: 905-906. 10.1002/bjs.1800741011.CrossRef Carpenter R, Gibbs N, Matthews J, Cooke T: Importance of cellular DNA content in pre-malignant breast disease and pre-invasive carcinoma of the female breast. Br J Surg. 1985, 74: 905-906. 10.1002/bjs.1800741011.CrossRef
34.
go back to reference Hoque A, Lippman SM, Boiko IV, Atkinson EN, Sneige N, Sahin A, Weber DM, Risin S, Lagios MD, Schwarting R, Colburn WJ, Dhingra K, Follen M, Kelloff GJ, Boone CW, Hittelman WN: Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast. Cancer Epidemiol Biomark Prev. 2001, 10: 249-259. Hoque A, Lippman SM, Boiko IV, Atkinson EN, Sneige N, Sahin A, Weber DM, Risin S, Lagios MD, Schwarting R, Colburn WJ, Dhingra K, Follen M, Kelloff GJ, Boone CW, Hittelman WN: Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast. Cancer Epidemiol Biomark Prev. 2001, 10: 249-259.
35.
go back to reference Mariuzzi GM, Mariuzzi L, Mombello A, Santinelli A, Valli M, Rahal D, Thompson D, Bartels PH: Quantitative study of ductal breast cancer progression. A progression index (P.I.) for premalignant lesions and in situ carcinoma. Pathol Res Pract. 1996, 192: 428-436.CrossRefPubMed Mariuzzi GM, Mariuzzi L, Mombello A, Santinelli A, Valli M, Rahal D, Thompson D, Bartels PH: Quantitative study of ductal breast cancer progression. A progression index (P.I.) for premalignant lesions and in situ carcinoma. Pathol Res Pract. 1996, 192: 428-436.CrossRefPubMed
36.
go back to reference Mommers ECM, Poulin N, Sangulin J, Meijer CJ, Baak JP, van Diest PJ: Nuclear cytometric changes in breast carcinogenesis. J Pathol. 2001, 193: 33-39. 10.1002/1096-9896(2000)9999:9999<::AID-PATH744>3.0.CO;2-Q.CrossRefPubMed Mommers ECM, Poulin N, Sangulin J, Meijer CJ, Baak JP, van Diest PJ: Nuclear cytometric changes in breast carcinogenesis. J Pathol. 2001, 193: 33-39. 10.1002/1096-9896(2000)9999:9999<::AID-PATH744>3.0.CO;2-Q.CrossRefPubMed
37.
go back to reference Veltri RW, Khan MA, Miller MC, Epstein JI, Mangold LA, Walsh PC, Partin AW: Ability to predict metastasis based on pathology findings and alterations in nuclear structure of normal-appearing and cancer peripheral zone epithelium in the prostate. Clin Cancer Res. 2004, 10: 3465-3473. 10.1158/1078-0432.CCR-03-0635.CrossRefPubMed Veltri RW, Khan MA, Miller MC, Epstein JI, Mangold LA, Walsh PC, Partin AW: Ability to predict metastasis based on pathology findings and alterations in nuclear structure of normal-appearing and cancer peripheral zone epithelium in the prostate. Clin Cancer Res. 2004, 10: 3465-3473. 10.1158/1078-0432.CCR-03-0635.CrossRefPubMed
38.
go back to reference Verhest A, Kiss R, d'Olne D, Larsimont D, Salmon I, de Launoit Y, Fourneau C, Pastells J-L, Pector J-C: Characterization of human colorectal mucosa, polyps, and cancers by means of computerized morphonuclear image analysis. Cancer. 1990, 65: 2047-2054. 10.1002/1097-0142(19900501)65:9<2047::AID-CNCR2820650926>3.0.CO;2-4.CrossRefPubMed Verhest A, Kiss R, d'Olne D, Larsimont D, Salmon I, de Launoit Y, Fourneau C, Pastells J-L, Pector J-C: Characterization of human colorectal mucosa, polyps, and cancers by means of computerized morphonuclear image analysis. Cancer. 1990, 65: 2047-2054. 10.1002/1097-0142(19900501)65:9<2047::AID-CNCR2820650926>3.0.CO;2-4.CrossRefPubMed
39.
go back to reference Solin LJ: Is excision alone adequate treatment for low-risk ductal carcinoma-in-situ of the breast?. J Clin Oncol. 2006, 24: 1017-1019. 10.1200/JCO.2005.04.4610.CrossRefPubMed Solin LJ: Is excision alone adequate treatment for low-risk ductal carcinoma-in-situ of the breast?. J Clin Oncol. 2006, 24: 1017-1019. 10.1200/JCO.2005.04.4610.CrossRefPubMed
Metadata
Title
Ductal carcinoma in situ of the breast (DCIS) with heterogeneity of nuclear grade: prognostic effects of quantitative nuclear assessment
Authors
Judith-Anne W Chapman
Naomi A Miller
H Lavina A Lickley
Jin Qian
William A Christens-Barry
Yuejiao Fu
Yan Yuan
David E Axelrod
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2007
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-7-174

Other articles of this Issue 1/2007

BMC Cancer 1/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine